JPY5,327.00
2.05% yesterday
Tokyo, Nov 15, 07:15 am CET
ISIN
JP3301100008
Symbol
4967
Sector
Industry

Kobayashi Pharmaceutical Target price 2024 - Analyst rating & recommendation

Kobayashi Pharmaceutical Classifications & Recommendation:

Buy
13%
Hold
75%
Sell
13%

Kobayashi Pharmaceutical Price Target

Target Price JPY5,806.25
Price JPY5,314.00
Potential
Number of Estimates 8
8 Analysts have issued a price target Kobayashi Pharmaceutical 2025 . The average Kobayashi Pharmaceutical target price is JPY5,806.25. This is higher than the current stock price. The highest price target is
JPY7,000.00 31.73%
register free of charge
, the lowest is
JPY4,900.00 7.79%
register free of charge
.
A rating was issued by 8 analysts: 1 Analysts recommend Kobayashi Pharmaceutical to buy, 6 to hold and 1 to sell.
Analysts don't have a crystal ball either, but they do represent the opinion of the market quite well. You should not take the price potential and the ratings as a recommendation to act. Rather, they serve as an additional building block for your own opinion or stock analysis.
Analyst Estimates: Analysts believe that the Kobayashi Pharmaceutical stock has an average upside potential 2025 of . Most analysts recommend the Kobayashi Pharmaceutical stock at Hold.

Sales and Margin forecast 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Revenue Billion JPY 173.46 168.90
4.33% 2.62%
EBITDA Margin 18.36% 19.09%
4.23% 4.00%
Net Margin 11.49% 7.17%
0.99% 37.61%

8 Analysts have issued a sales forecast Kobayashi Pharmaceutical 2024 . The average Kobayashi Pharmaceutical sales estimate is

JPY169b
Unlock
. This is
0.06% higher
Unlock
than the revenue of the last 12 months(TTM). The highest sales forecast is
JPY170b 0.95%
Unlock
, the lowest is
JPY167b 0.94%
Unlock
.

This results in the following potential growth metrics:

Revenue Estimates

2023 JPY173b 4.33%
2024
JPY169b 2.62%
Unlock
2025
JPY177b 4.70%
Unlock
2026
JPY184b 4.25%
Unlock
2027
JPY189b 2.59%
Unlock
2028
JPY194b 2.42%
Unlock

6 Analysts have issued an Kobayashi Pharmaceutical EBITDA forecast 2024. The average Kobayashi Pharmaceutical EBITDA estimate is

JPY32.2b
Unlock
. This is
3.80% higher
Unlock
than the EBITDA of the last 12 months(TTM). The highest EBITDA forecast is
JPY33.9b 9.21%
Unlock
, the lowest is
JPY30.5b 1.76%
Unlock
.

This results in the following potential growth metrics and future EBITDA Margins:

EBITDA Estimates

2023 JPY31.8b 0.08%
2024
JPY32.2b 1.26%
Unlock
2025
JPY32.0b 0.59%
Unlock
2026
JPY33.7b 5.17%
Unlock
2027
JPY33.0b 2.24%
Unlock
2028
JPY29.6b 10.17%
Unlock

EBITDA Margin

2023 18.36% 4.23%
2024
19.09% 4.00%
Unlock
2025
18.12% 5.08%
Unlock
2026
18.28% 0.88%
Unlock
2027
17.42% 4.70%
Unlock
2028
15.28% 12.28%
Unlock

4 Kobayashi Pharmaceutical Analysts have issued a net profit forecast 2024. The average Kobayashi Pharmaceutical net profit estimate is

JPY12.1b
Unlock
. This is
19.48% higher
Unlock
than the net profit for the last 12 months(TTM). The highest net profit forecast is
JPY13.6b 34.25%
Unlock
, the lowest is
JPY10.1b 0.04%
Unlock
.

This results in the following potential growth metrics and future Net Margins:

Net Profit Estimates

2023 JPY19.9b 3.29%
2024
JPY12.1b 39.24%
Unlock
2025
JPY17.7b 45.85%
Unlock
2026
JPY18.9b 6.95%
Unlock
2027
JPY19.7b 4.26%
Unlock

Net Margin

2023 11.49% 0.99%
2024
7.17% 37.61%
Unlock
2025
9.99% 39.33%
Unlock
2026
10.25% 2.60%
Unlock
2027
10.42% 1.66%
Unlock

Earnings per share, P/E ratio and EV/sales Estimates 2024, 2025 to 2028

Create a premium account to unlock analyst estimates. Learn more

Quarter Annually
Dec '23 2024
Estimates
Earnings Per Share JPY 268.16 162.94
3.29% 39.24%
P/E 32.61
EV/Sales 2.04

4 Analysts have issued a Kobayashi Pharmaceutical forecast for earnings per share. The average Kobayashi Pharmaceutical <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS is

JPY162.94
Unlock
. This is
19.48% higher
Unlock
than earnings per share in the financial year 2023. The highest <a href=https://blog.stocksguide.com/knowledge/eps-simply-explained>EPS forecast is
JPY183.07 34.25%
Unlock
, the lowest is
JPY136.42 0.04%
Unlock
.

This results in the following potential growth metrics and future valuations:

Earnings Per Share

2023 JPY268.16 3.29%
2024
JPY162.94 39.24%
Unlock
2025
JPY237.65 45.85%
Unlock
2026
JPY254.17 6.95%
Unlock
2027
JPY265.00 4.26%
Unlock

P/E ratio

Current 38.97 57.39%
2024
32.61 16.32%
Unlock
2025
22.36 31.43%
Unlock
2026
20.91 6.48%
Unlock
2027
20.05 4.11%
Unlock

Based on analysts' sales estimates for 2024, the Kobayashi Pharmaceutical stock is valued at an <a href=https://blog.stocksguide.com/knowledge/enterprise-value-sales-simply-explained>EV/Sales of

and an <a href=https://blog.stocksguide.com/knowledge/price-sales-ratio-simply-explained>P/S ratio of .

This results in the following potential growth metrics and future valuations:

EV/Sales

Current 2.04 18.07%
2024
2.04 0.06%
Unlock
2025
1.95 4.49%
Unlock
2026
1.87 4.08%
Unlock
2027
1.82 2.52%
Unlock
2028
1.78 2.36%
Unlock

P/S ratio

Current 2.34 23.12%
2024
2.34 0.06%
Unlock
2025
2.23 4.49%
Unlock
2026
2.14 4.08%
Unlock
2027
2.09 2.52%
Unlock
2028
2.04 2.36%
Unlock

Register for Free

StocksGuide is the ultimate tool for easily finding, analyzing and tracking stocks. Learn from successful investors and make informed investment decisions. We empower you to become a confident, independent investor.

The Apple stock at a glance with charts, current key metrics, news and stock analyses.
The Best Dividend Stocks in the Dividend Top Scorer list.
Stock Analyses of the Best Stocks Worldwide.
Start building wealth today